CORC

在结果中检索

CORC

浏览/检索结果: 共572条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Opportunities and challenges of fucoidan for tumors therapy 期刊论文
CARBOHYDRATE POLYMERS, 2024, 卷号: 324, 页码: 13
作者:  Yu, Haoyu;  Zhang, Quanbin;  Farooqi, Ammad Ahmad;  Wang, Jing;  Yue, Yang
收藏  |  浏览/下载：1/0  |  提交时间：2024/04/07
Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy 期刊论文
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13
作者:  Hua, Chen;  Shena, Lijuan;  Zoua, Fengming;  Wua, Yun;  Wanga, Beilei
收藏  |  浏览/下载：7/0  |  提交时间：2023/11/10
Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61
作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong
收藏  |  浏览/下载：17/0  |  提交时间：2022/12/22
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi
收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23
Bibliometric and visual analysis in the field of ketogenic diet on cancer from 2012 to 2021 期刊论文
FRONTIERS IN NUTRITION, 2022, 卷号: 9
作者:  Li, Rongrong;  Huang, Qingcheng;  Ye, Chenxiao;  Wu, Changhong;  Luo, Ning
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang
收藏  |  浏览/下载：92/0  |  提交时间：2022/03/28
Oxygen Self-Supply Engineering-Ferritin for the Relief of Hypoxia in Tumors and the Enhancement of Photodynamic Therapy Efficacy 期刊论文
SMALL, 2022
作者:  Zhu, Yang;  Jin, Duo;  Liu, Manman;  Dai, Yi;  Li, Li
收藏  |  浏览/下载：96/0  |  提交时间：2022/03/28
GPR30 Activation Promotes the Progression of Gastric Cancer and Plays a Significant Role in the Anti-GC Effect of Huaier 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Wang, Xiao-feng;  Hu, Can;  Mo, Shao-Wei;  Xu, Jing-Li;  Liu, Yan
收藏  |  浏览/下载：22/0  |  提交时间：2022/05/16
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao
收藏  |  浏览/下载：42/0  |  提交时间：2022/02/14
Nardoguaianone L isolated from Nardostachys jatamansi improved the effect of gemcitabine chemotherapy via regulating AGE signaling pathway in SW1990 cells 期刊论文
Molecules, 2022, 期号: 27, 页码: 6849
作者:  Yi-Dan Zheng;  Li-Mei Ma;  Jin-Jian Lu;  Tian Chai;  Mohammad Reza Naghavi
收藏  |  浏览/下载：10/0  |  提交时间：2022/11/30

©版权所有 ©2017 CSpace - Powered by CSpace